| Detected | Trial | Change |
|---|---|---|
| 2026-07-28 | NCT07260877 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an… |
Trial sites expanded: 27 -> 32 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07260877 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an… | Cutaneous Lupus Erythematosus (CLE) | Recruiting |